Senior researchers and medical students at Weill Cornell Medicine-Qatar (WCM-Q) have published a paper focused on improving drug-screening platforms for vascular diseases. The research team, led by Dr Isra Marei, post-doctoral associate in pharmacology, includes four members of WCM-Q’s Class of 2024 - Tala Abu Samaan, Maryam Ali al-Quradaghi, Asmaa A Farah and Shamin Hayat Mahmud – plus Prof Chris Triggle, professor of pharmacology, and associate professor of pharmacology Hong Ding. The study has been published in Frontiers in Cardiovascular Medicine as an invited review for a special issue on regenerative medicine and is titled, ‘3D tissue-engineered vascular drug screening platforms:
Hence then, the article about wcm q publishes study on 3d tissue engineered drug screening platforms was published today ( ) and is available onGulf Times ( Qatar ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( WCM-Q publishes study on 3D tissue-engineered drug screening platforms )